Anebulo Pharmaceuticals Inc (ANEB)
1.84
-0.04
(-2.13%)
USD |
NASDAQ |
Nov 01, 16:00
Anebulo Pharmaceuticals Shareholders Equity (Quarterly): 3.812M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.812M |
| March 31, 2024 | 4.985M |
| December 31, 2023 | 6.487M |
| September 30, 2023 | 8.331M |
| June 30, 2023 | 10.60M |
| March 31, 2023 | 12.94M |
| December 31, 2022 | 15.52M |
| September 30, 2022 | 19.12M |
| Date | Value |
|---|---|
| June 30, 2022 | 15.07M |
| March 31, 2022 | 17.16M |
| December 31, 2021 | 18.91M |
| September 30, 2021 | 19.89M |
| June 30, 2021 | 21.41M |
| March 31, 2021 | -9.436M |
| December 31, 2020 | -0.719M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-9.436M
Minimum
Mar 2021
21.41M
Maximum
Jun 2021
10.94M
Average
12.94M
Median
Mar 2023
Shareholders Equity (Quarterly) Benchmarks
| Revance Therapeutics Inc | -129.74M |
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.073M |
| Total Liabilities (Quarterly) | 0.2606M |